- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Idelalisib – July 2016
Idelalisib: 100 mg tablet, 60, 150 mg tablet, 60, Zydelig®, chronic lymphocytic leukaemia
Last updated
28 October 2016